122 related articles for article (PubMed ID: 37863310)
1. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Rossi G; Salmanton-García J; Cattaneo C; Marchesi F; Dávila-Valls J; Martín-Pérez S; Itri F; López-García A; Glenthøj A; Gomes da Silva M; Besson C; Marchetti M; Weinbergerová B; Jaksic O; Jiménez M; Bilgin YM; Van Doesum J; Farina F; Žák P; Verga L; Collins GP; Bonuomo V; Van Praet J; Nucci M; Meers S; Espigado I; Fracchiolla NS; Valković T; Poulsen CB; Čolović N; Dragonetti G; Ledoux MP; Tascini C; Buquicchio C; Blennow O; Passamonti F; Machado M; Labrador J; Duarte RF; Schönlein M; Prezioso L; Falces-Romero I; Kulasekararaj A; Garcia-Vidal C; Fernández N; Abu-Zeinah G; Ormazabal-Vélez I; Adžić-Vukičević T; Piukovics K; Stoma I; Cuccaro A; Magliano G; Szotkowski T; González-López TJ; El-Ashwah S; Bergantim R; Sili U; Maertens J; Demirkan F; De Ramón C; Petzer V; Del Principe MI; Navrátil M; Dargenio M; Seval GC; Samarkos M; Ráčil Z; Pinczés LI; Lahmer T; Busca A; Méndez GA; Vena A; Biernat MM; Merelli M; Calbacho M; Barać A; Bavastro M; Limongelli A; Ilhan O; Wolf D; Çolak GM; García-Sanz R; Emarah Z; Mišković B; Gräfe SK; Mladenović M; Aiello TF; Núñez-Martín-Buitrago L; Nordlander A; Arellano E; Zambrotta GPM; Ammatuna E; Cabirta A; Sacchi MV; Nunes Rodrigues R; Hersby DS; Hanakova M; Rahimli L; Cordoba R; Cornely OA; Pagano L;
Int J Infect Dis; 2023 Dec; 137():98-110. PubMed ID: 37863310
[TBL] [Abstract][Full Text] [Related]
2. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
[TBL] [Abstract][Full Text] [Related]
4. Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
Marchesi F; Salmanton-García J; Buquicchio C; Itri F; Besson C; Dávila-Valls J; Martín-Pérez S; Fianchi L; Rahimli L; Tarantini G; Grifoni FI; Sciume M; Labrador J; Cordoba R; López-García A; Fracchiolla NS; Farina F; Ammatuna E; Cingolani A; García-Bordallo D; Gräfe SK; Bilgin YM; Dargenio M; González-López TJ; Guidetti A; Lahmer T; Lavilla-Rubira E; Méndez GA; Prezioso L; Schönlein M; Van Doesum J; Wolf D; Hersby DS; Magyari F; Van Praet J; Petzer V; Tascini C; Falces-Romero I; Glenthøj A; Cornely OA; Pagano L
J Hematol Oncol; 2023 Apr; 16(1):32. PubMed ID: 37005697
[TBL] [Abstract][Full Text] [Related]
5. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Salmanton-García J; Marchesi F; Koehler P; Weinbergerová B; Čolović N; Falces-Romero I; Buquicchio C; Farina F; van Praet J; Biernat MM; Itri F; Prezioso L; Tascini C; Vena A; Romano A; Delia M; Dávila-Valls J; Martín-Pérez S; Lavilla-Rubira E; Adžić-Vukičević T; García-Bordallo D; López-García A; Criscuolo M; Petzer V; Fracchiolla NS; Espigado I; Sili U; Meers S; Erben N; Cattaneo C; Tragiannidis A; Gavriilaki E; Schönlein M; Mitrovic M; Pantic N; Merelli M; Labrador J; Hernández-Rivas JÁ; Glenthøj A; Fouquet G; Del Principe MI; Dargenio M; Calbacho M; Besson C; Kohn M; Gräfe S; Hersby DS; Arellano E; Çolak GM; Wolf D; Marchetti M; Nordlander A; Blennow O; Cordoba R; Mišković B; Mladenović M; Bavastro M; Limongelli A; Rahimli L; Pagano L; Cornely OA
Int J Antimicrob Agents; 2023 Oct; 62(4):106952. PubMed ID: 37582478
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies.
Noori M; Azizi S; Abbasi Varaki F; Nejadghaderi SA; Bashash D
Int Immunopharmacol; 2022 Sep; 110():109046. PubMed ID: 35843148
[TBL] [Abstract][Full Text] [Related]
7. Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Salmanton-García J; Marchesi F; Farina F; Weinbergerová B; Itri F; Dávila-Valls J; Martín-Pérez S; Glenthøj A; Hersby DS; Gomes da Silva M; Nunes Rodrigues R; López-García A; Córdoba R; Bilgin YM; Falces-Romero I; El-Ashwah S; Emarah Z; Besson C; Kohn M; Van Doesum J; Ammatuna E; Marchetti M; Labrador J; Zambrotta GPM; Verga L; Jaksic O; Nucci M; Piukovics K; Cabirta-Touzón A; Jiménez M; Arellano E; Espigado I; Blennow O; Nordlander A; Meers S; van Praet J; Aiello TF; Garcia-Vidal C; Fracchiolla N; Sciumè M; Seval GC; Žák P; Buquicchio C; Tascini C; Gräfe SK; Schönlein M; Adžić-Vukičević T; Bonuomo V; Cattaneo C; Nizamuddin S; Čerňan M; Plantefeve G; Prin R; Szotkovski T; Collins GP; Dargenio M; Petzer V; Wolf D; Čolović N; Prezioso L; Valković T; Passamonti F; Méndez GA; Sili U; Vena A; Bavastro M; Limongelli A; Duarte RF; Ledoux MP; Cvetanoski M; Stojanoski Z; Machado M; Batinić J; Magliano G; Biernat MM; Pantić N; Poulsen CB; Cuccaro A; Del Principe MI; Kulasekararaj A; Ormazabal-Vélez I; Busca A; Demirkan F; Ijaz M; Klimko N; Stoma I; Khostelidi S; Fernández N; Omrani AS; Bergantim R; De Jonge N; Fouquet G; Navrátil M; Abu-Zeinah G; Samarkos M; Maertens J; De Ramón C; Guidetti A; Magyari F; González-López TJ; Lahmer T; Finizio O; Ali N; Pinczés LI; Lavilla-Rubira E; Romano A; Merelli M; Delia M; Calbacho M; Meletiadis J; Antić D; Hernández-Rivas JÁ; Marques de Almeida J; Al-Khabori M; Hoenigl M; Tisi MC; Khanna N; Barać A; Eisa N; Di Blasi R; Liévin R; Miranda-Castillo C; Bahr NC; Lamure S; Papa MV; Yahya A; Aujayeb A; Novák J; Erben N; Fernández-Galán M; Ribera-Santa Susana JM; Rinaldi I; Fazzi R; Piedimonte M; Duléry R; Gonzaga Y; Soto-Silva A; Sapienza G; Serris A; Drgoňa Ľ; Groh A; Serrano L; Gavriilaki E; Tragiannidis A; Prattes J; Coppola N; Otašević V; Mladenović M; Mitrović M; Mišković B; Jindra P; Zompi S; Sacchi MV; Krekeler C; Infante MS; García-Bordallo D; Çolak GM; Mayer J; Nygaard M; Hanáková M; Ráčil Z; Bonanni M; Koehler P; Rahimli L; Cornely OA; Pagano L;
EClinicalMedicine; 2024 May; 71():102553. PubMed ID: 38533127
[TBL] [Abstract][Full Text] [Related]
8. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Pagano L; Salmanton-García J; Marchesi F; Blennow O; Gomes da Silva M; Glenthøj A; van Doesum J; Bilgin YM; López-García A; Itri F; Nunes Rodrigues R; Weinbergerová B; Farina F; Dragonetti G; Berg Venemyr C; van Praet J; Jaksic O; Valković T; Falces-Romero I; Martín-Pérez S; Jiménez M; Dávila-Valls J; Schönlein M; Ammatuna E; Meers S; Delia M; Stojanoski Z; Nordlander A; Lahmer T; Imre Pinczés L; Buquicchio C; Piukovics K; Ormazabal-Vélez I; Fracchiolla N; Samarkos M; Méndez GA; Hernández-Rivas JÁ; Espigado I; Cernan M; Petzer V; Lamure S; di Blasi R; Marques de Almedia J; Dargenio M; Biernat MM; Sciumè M; de Ramón C; de Jonge N; Batinić J; Aujayeb A; Marchetti M; Fouquet G; Fernández N; Zambrotta G; Sacchi MV; Guidetti A; Demirkan F; Prezioso L; Ráčil Z; Nucci M; Mladenović M; Liévin R; Hanáková M; Gräfe S; Sili U; Machado M; Cattaneo C; Adžić-Vukičević T; Verga L; Labrador J; Rahimli L; Bonanni M; Passamonti F; Pagliuca A; Corradini P; Hoenigl M; Koehler P; Busca A; Cornely OA
Blood; 2022 Dec; 140(26):2773-2787. PubMed ID: 36126318
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Marchetti M; Salmanton-García J; El-Ashwah S; Verga L; Itri F; Ráčil Z; Dávila-Valls J; Martín-Pérez S; Van Doesum J; Passamonti F; Abu-Zeinah G; Farina F; López-García A; Dragonetti G; Cattaneo C; Gomes Da Silva M; Bilgin YM; Žák P; Petzer V; Glenthøj A; Espigado I; Buquicchio C; Bonuomo V; Prezioso L; Meers S; Duarte R; Bergantim R; Jaksic O; Čolović N; Blennow O; Cernan M; Schönlein M; Samarkos M; Mitra ME; Magliano G; Maertens J; Ledoux MP; Jiménez M; Demirkan F; Collins GP; Cabirta A; Gräfe SK; Nordlander A; Wolf D; Arellano E; Cordoba R; Hanakova M; Zambrotta GPM; Nunes Rodrigues R; Limberti G; Marchesi F; Cornely OA; Pagano L
Ther Adv Hematol; 2023; 14():20406207231154706. PubMed ID: 36923264
[TBL] [Abstract][Full Text] [Related]
10. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.
Borah P; Mirgh S; Sharma SK; Bansal S; Dixit A; Dolai TK; Lunkad S; Gupta N; Singh G; Jain A; Bansal D; Choudhary D; Khandelwal V; Doval D; Kumar M; Bhargava R; Chakrabarti A; Kalashetty M; Rauthan A; Kazi B; Mandal PK; Jeyaraman P; Naithani R;
Blood Cells Mol Dis; 2021 Mar; 87():102525. PubMed ID: 33338697
[TBL] [Abstract][Full Text] [Related]
11. The outcome of COVID-19 in patients with hematological malignancy.
Yigenoglu TN; Ata N; Altuntas F; Bascı S; Dal MS; Korkmaz S; Namdaroglu S; Basturk A; Hacıbekiroglu T; Dogu MH; Berber İ; Dal K; Erkurt MA; Turgut B; Ulgu MM; Celik O; Imrat E; Birinci S
J Med Virol; 2021 Feb; 93(2):1099-1104. PubMed ID: 32776581
[TBL] [Abstract][Full Text] [Related]
12. Differences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain).
Ramos-Rincon JM; Cobos-Palacios L; López-Sampalo A; Ricci M; Rubio-Rivas M; Nuñez-Rodriguez MV; Miranda-Godoy R; García-Leoni ME; Fernández-Madera-Martínez R; García-García GM; Beato-Perez JL; Monge-Monge D; Asín-Samper U; Bustamante-Vega M; Rábago-Lorite I; Freire-Castro SJ; Miramontes-González JP; Magallanes-Gamboa JO; Alcalá-Pedrajas JN; García-Gómez M; Cano-Llorente V; Carrasco-Sánchez FJ; Martinez-Carrilero J; Antón-Santos JM; Gómez-Huelgas R;
BMC Geriatr; 2022 Jun; 22(1):546. PubMed ID: 35773622
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
Kim JS; Lee KH; Kim GE; Kim S; Yang JW; Li H; Hong SH; Ghayda RA; Kronbichler A; Koyanagi A; Jacob L; Shin JI; Smith L
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11926-11933. PubMed ID: 33275265
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.
Naimi A; Yashmi I; Jebeleh R; Imani Mofrad M; Azimian Abhar S; Jannesar Y; Heidary M; Pakzad R
J Clin Lab Anal; 2022 May; 36(5):e24387. PubMed ID: 35385130
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Clinical Features and Outcomes in Elderly Patients during Six Pandemic Waves.
Fericean RM; Rosca O; Citu C; Manolescu D; Bloanca V; Toma AO; Boeriu E; Dumitru C; Ravulapalli M; Barbos V; Oancea C
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431282
[TBL] [Abstract][Full Text] [Related]
17. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
Guven DC; Sahin TK; Akın S; Uckun FM
Oncologist; 2022 Apr; 27(4):e357-e361. PubMed ID: 35274729
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.
Goudsmit A; Cubilier E; Meert AP; Aftimos P; Stathopoulos K; Spilleboudt C; Loizidou A
Support Care Cancer; 2021 Nov; 29(11):6271-6278. PubMed ID: 33851236
[TBL] [Abstract][Full Text] [Related]
19. "Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan".
Zaki A; Soomar SM; Khan DH; Shaharyar Sheikh H; Iftikhar R; Mir A; Aziz Z; Bano K; Naseer H; Chaudhry QU; Bokhari SWI; Shabbir-Moosajee M
PLoS One; 2022; 17(4):e0267139. PubMed ID: 35446898
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in patients with hematologic malignancy.
Langerbeins P; Hallek M
Blood; 2022 Jul; 140(3):236-252. PubMed ID: 35544585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
